Andrew Martin

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

Ian D. Davis, Andrew Martin, Martin R. Stockler et al. · New England Journal of Medicine · 2019 · 1.6K citations

Pharmacy, Oncology, Pharmacotherapy +17

[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

Michael S. Hofman, Louise Emmett, Shahneen Sandhu et al. · The Lancet · 2021 · 1.1K citations

Medicine, Oncology, Pharmacology +12

The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL

Clare Bradley, Chris Todd, Tessa Gorton et al. · Quality of Life Research · 1999 · 671 citations

Pharmacy, Psychology, Health Assessment +13

A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention

Andrew C. Chen, Andrew Martin, Bonita Choy et al. · New England Journal of Medicine · 2015 · 628 citations

Medicine, Dermatology, Oncology +15

Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

Matthew Clarke, Alan Mackay, Britta Ismer et al. · Cancer Discovery · 2020 · 278 citations · Full text

Medicine, Molecular Genetics, Oncology +17